Dr. Stephen Mark Wolchok, MD

Dr. Wolchok practices at Wolchok Eye Associates, P.A. in Jacksonville, Florida.

Dr. Wolchok's NPI, 1740324102, was assigned on February 19, 2007. Dr. Wolchok graduated from University Of Florida College Of Medicine in 2001. Dr. Wolchok holds Florida license ME97993.

Dr. Wolchok's primary practice is Wolchok Eye Associates, P.A., at 3636 University S Blvd, Jacksonville, FL 32216 in Duval County. The practice phone is (904) 739-0606.

Dr. Wolchok's primary practice is Wolchok Eye Associates, P.A. in Jacksonville, Florida. Dmand AI also links Dr. Wolchok to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wolchok practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Wolchok's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Wolchok is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Wolchok's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Wolchok treats.

CMS data shows 3,140 Medicare services from Dr. Wolchok across 17 procedure codes in 2024, for 1,182 Medicare patients. Medicare paid $274,073 for them.

CMS counts 1,182 Medicare patients who saw Dr. Wolchok in 2024. The largest group is 75 to 84, with 523 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wolchok's median patient age at 74, with 57% women.

In 2024, Dr. Wolchok wrote 2,132 Medicare Part D claims for 630 patients. 66% of them were for generic drugs. CMS names the drug for 1,990 of them, across 22 drugs with 11 or more claims each, at $177,385 in total drug cost. In 2023, CMS named 1,863 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Wolchok for performance year 2024, reported individually. Dr. Wolchok accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wolchok as offering telehealth. CMS counts 138 procedures of cataract surgery by Dr. Wolchok, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Wolchok. The most frequent topics are Adaptation, Psychological and Precursor Cell Lymphoblastic Leukemia-Lymphoma. Dr. Wolchok's most frequent co-author is Roy E. Weiss, MD.

CMS Open Payments shows 57 general payments to Dr. Wolchok from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Alcon Laboratories Inc paid the most, $416.

Dmand AI lists 1 award for Dr. Wolchok.

Dr. Wolchok graduated from University Of Florida College Of Medicine in 2001. Dr. Wolchok is a member of AAO.

Dr. Wolchok is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.